Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Asset Utilization Ratio (2016 - 2026)

Ani Pharmaceuticals' Asset Utilization Ratio history spans 15 years, with the latest figure at 0.62 for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 29.82% to 0.62 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.62, a 29.82% increase, with the full-year FY2025 number at 0.65, up 15.5% from a year prior.
  • Asset Utilization Ratio hit 0.62 in Q4 2025 for Ani Pharmaceuticals, up from 0.6 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for ANIP hit a ceiling of 0.62 in Q4 2025 and a floor of 0.28 in Q4 2021.
  • Historically, Asset Utilization Ratio has averaged 0.46 across 5 years, with a median of 0.49 in 2023.
  • Biggest five-year swings in Asset Utilization Ratio: plummeted 38.35% in 2021 and later soared 57.73% in 2023.
  • Tracing ANIP's Asset Utilization Ratio over 5 years: stood at 0.28 in 2021, then surged by 51.68% to 0.42 in 2022, then increased by 28.56% to 0.54 in 2023, then fell by 11.95% to 0.48 in 2024, then rose by 29.82% to 0.62 in 2025.
  • Business Quant data shows Asset Utilization Ratio for ANIP at 0.62 in Q4 2025, 0.6 in Q3 2025, and 0.57 in Q2 2025.